Drug treatment for cancer of the corpus uteri: Protracted stagnation or breakthrough expectation
The paper considers the specific features of the course and therapy of cancer of the corpus uteri on the basis of some clinical and biological characteristics of the tumor. The objective of ongoing and future clinical trials is to expand the arsenal of active drugs and to individualize therapy in pa...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
ABV-press,
2014-08-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_ab2a70aeb98e4f99a4b35a758db15208 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a E. V. Artamonova |e author |
| 245 | 0 | 0 | |a Drug treatment for cancer of the corpus uteri: Protracted stagnation or breakthrough expectation |
| 260 | |b ABV-press, |c 2014-08-01T00:00:00Z. | ||
| 500 | |a 1994-4098 | ||
| 500 | |a 1999-8627 | ||
| 500 | |a 10.17650/1994-4098-2011-0-3-83-87 | ||
| 520 | |a The paper considers the specific features of the course and therapy of cancer of the corpus uteri on the basis of some clinical and biological characteristics of the tumor. The objective of ongoing and future clinical trials is to expand the arsenal of active drugs and to individualize therapy in patients with endometrial cancer. | ||
| 546 | |a RU | ||
| 690 | |a endometrial cancer | ||
| 690 | |a molecular genetic markers | ||
| 690 | |a treatment | ||
| 690 | |a Gynecology and obstetrics | ||
| 690 | |a RG1-991 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Опухоли женской репродуктивной системы, Vol 0, Iss 3, Pp 83-87 (2014) | |
| 787 | 0 | |n https://ojrs.abvpress.ru/ojrs/article/view/183 | |
| 787 | 0 | |n https://doaj.org/toc/1994-4098 | |
| 787 | 0 | |n https://doaj.org/toc/1999-8627 | |
| 856 | 4 | 1 | |u https://doaj.org/article/ab2a70aeb98e4f99a4b35a758db15208 |z Connect to this object online. |